Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Aug;83(15):5377–5381. doi: 10.1073/pnas.83.15.5377

Potential proteolytic activity of human plasma fibronectin.

V Keil-Dlouha, T Planchenault
PMCID: PMC386289  PMID: 3526328

Abstract

Evidence is presented that fibronectin (FN) polypeptide chain contains a latent proteinase. Human plasma FN was cleaved with cathepsin D into three main fragments: 140-kDa and 70-kDa single-chain and 140-kDa double-chain polypeptides. Their separation was achieved according to their affinity for heparin-Sepharose. A single-chain 140-kDa fragment (H-1) was eluted in the first peak. This peptide corresponds to the already described fragment that originates from the central part of FN; it contains a low-affinity heparin-binding site, one free SH group, and a cell-binding site. After reduction and further purification by preparative polyacrylamide gel electrophoresis, this fragment revealed a spontaneous decomposition, which could be attributed to proteolytic degradation. The subfragments, ranging from 25 to 95 kDa, yielded the same proteolytically active doublet of 28-30 kDa when tested by NaDodSO4/polyacrylamide gel electrophoresis in a gel containing copolymerized gelatin or fibrinogen. The proteolytic activity was inhibited by specific SH proteinase inhibitors. The proteinase forms a labeled complex after its incubation with 125I-labeled cystatin. Neither FN, cathepsin D, nor any products from previous purification steps were proteolytically active under the conditions of the assay. It was suggested that the same fragment may also yield an inhibitor, since structural analogies were found between the cell-binding region of FN and SH proteinase inhibitors.

Full text

PDF
5377

Images in this article

5378Image
on p.5378
5378Image
on p.5378
5378Image
on p.5378
5378Image
on p.5378
5378Image
on p.5378
5379Image
on p.5379
5379Image
on p.5379
5379Image
on p.5379
5379Image
on p.5379
5379Image
on p.5379
5379Image
on p.5379
5379Image
on p.5379
5379Image
on p.5379
5379Image
on p.5379
5380Image
on p.5380
5380Image
on p.5380

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALI S. Y., LACK C. H. STUDIES ON THE TISSUE ACTIVATOR OF PLASMINOGEN. DISTRIBUTION OF ACTIVATOR AND PROTEOLYTIC ACTIVITY IN THE SUBCELLULAR FRACTIONS OF RABBIT KIDNEY. Biochem J. 1965 Jul;96:63–74. doi: 10.1042/bj0960063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balian G., Click E. M., Crouch E., Davidson J. M., Bornstein P. Isolation of a collagen-binding fragment from fibronectin and cold-insoluble globulin. J Biol Chem. 1979 Mar 10;254(5):1429–1432. [PubMed] [Google Scholar]
  3. Brzin J., Popovic T., Turk V., Borchart U., Machleidt W. Human cystatin, a new protein inhibitor of cysteine proteinases. Biochem Biophys Res Commun. 1984 Jan 13;118(1):103–109. doi: 10.1016/0006-291x(84)91073-8. [DOI] [PubMed] [Google Scholar]
  4. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  5. Gold L. I., Frangione B., Pearlstein E. Biochemical and immunological characterization of three binding sites on human plasma fibronectin with different affinities for heparin. Biochemistry. 1983 Aug 16;22(17):4113–4119. doi: 10.1021/bi00286a019. [DOI] [PubMed] [Google Scholar]
  6. Heussen C., Dowdle E. B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem. 1980 Feb;102(1):196–202. doi: 10.1016/0003-2697(80)90338-3. [DOI] [PubMed] [Google Scholar]
  7. Hynes R. O., Yamada K. M. Fibronectins: multifunctional modular glycoproteins. J Cell Biol. 1982 Nov;95(2 Pt 1):369–377. doi: 10.1083/jcb.95.2.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Keil-Dlouha V., Joukoff E., Planchenault T. Plasmin regulating system from embryonal carcinoma F9 cells: plasminases A, B and embrinogen. Biochem Biophys Res Commun. 1984 Mar 15;119(2):758–766. doi: 10.1016/s0006-291x(84)80315-0. [DOI] [PubMed] [Google Scholar]
  9. Keil-Dlouha V., Paulin D., Bagilet L. K., Keil B. A comparison of surface proteins in embryonal carcinoma cells and their differentiated derivatives. Biochim Biophys Acta. 1980 Mar 27;597(1):15–28. doi: 10.1016/0005-2736(80)90146-7. [DOI] [PubMed] [Google Scholar]
  10. Kornblihtt A. R., Vibe-Pedersen K., Baralle F. E. Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res. 1984 Jul 25;12(14):5853–5868. doi: 10.1093/nar/12.14.5853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kornblihtt A. R., Vibe-Pedersen K., Baralle F. E. Isolation and characterization of cDNA clones for human and bovine fibronectins. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3218–3222. doi: 10.1073/pnas.80.11.3218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  13. Loskutoff D. J., Edgington T. E. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3903–3907. doi: 10.1073/pnas.74.9.3903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Macartney H. W., Tschesche H. Latent and active human polymorphonuclear leukocyte collagenases. Isolation, purification and characterisation. Eur J Biochem. 1983 Jan 17;130(1):71–78. doi: 10.1111/j.1432-1033.1983.tb07118.x. [DOI] [PubMed] [Google Scholar]
  15. Machleidt W., Borchart U., Fritz H., Brzin J., Ritonja A., Turk V. Protein inhibitors of cysteine proteinases. II. Primary structure of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes. Hoppe Seylers Z Physiol Chem. 1983 Nov;364(11):1481–1486. doi: 10.1515/bchm2.1983.364.2.1481. [DOI] [PubMed] [Google Scholar]
  16. Nolan C., Hall L. S., Barlow G. H., Tribby I. I. Plasminogen activator from human embryonic kidney cell cultures. Evidence for a proactivator. Biochim Biophys Acta. 1977 Feb 28;496(2):384–400. doi: 10.1016/0304-4165(77)90321-x. [DOI] [PubMed] [Google Scholar]
  17. O'Farrell P. H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975 May 25;250(10):4007–4021. [PMC free article] [PubMed] [Google Scholar]
  18. Ohkubo I., Kurachi K., Takasawa T., Shiokawa H., Sasaki M. Isolation of a human cDNA for alpha 2-thiol proteinase inhibitor and its identity with low molecular weight kininogen. Biochemistry. 1984 Nov 20;23(24):5691–5697. doi: 10.1021/bi00319a005. [DOI] [PubMed] [Google Scholar]
  19. Pande H., Shively J. E. NH2-terminal sequences of DNA-, heparin-, and gelatin-binding tryptic fragments from human plasma fibronectin. Arch Biochem Biophys. 1982 Jan;213(1):258–265. doi: 10.1016/0003-9861(82)90460-x. [DOI] [PubMed] [Google Scholar]
  20. Pena S. D., Mills G., Hughes R. C., Aplin J. D. Polypeptide heterogeneity of hamster and calf fibronectins. Biochem J. 1980 Aug 1;189(2):337–347. doi: 10.1042/bj1890337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Petersen T. E., Thøgersen H. C., Skorstengaard K., Vibe-Pedersen K., Sahl P., Sottrup-Jensen L., Magnusson S. Partial primary structure of bovine plasma fibronectin: three types of internal homology. Proc Natl Acad Sci U S A. 1983 Jan;80(1):137–141. doi: 10.1073/pnas.80.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Quigley J. P., Ossowski L., Reich E. Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses. J Biol Chem. 1974 Jul 10;249(13):4306–4311. [PubMed] [Google Scholar]
  23. Richter H., Hörmann H. A large cathepsin D-derived fragment from the central part of the fibronectin subunit chains. FEBS Lett. 1983 May 8;155(2):317–320. doi: 10.1016/0014-5793(82)80628-5. [DOI] [PubMed] [Google Scholar]
  24. Richter H., Hörmann H. Early and late cathepsin D-derived fragments of fibronectin containing the C-terminal interchain disulfide cross-link. Hoppe Seylers Z Physiol Chem. 1982 Apr;363(4):351–364. doi: 10.1515/bchm2.1982.363.1.351. [DOI] [PubMed] [Google Scholar]
  25. Smith D. E., Mosher D. F., Johnson R. B., Furcht L. T. Immunological identification of two sulfhydryl-containing fragments of human plasma fibronectin. J Biol Chem. 1982 May 25;257(10):5831–5838. [PubMed] [Google Scholar]
  26. Takio K., Kominami E., Bando Y., Katunuma N., Titani K. Amino acid sequence of rat epidermal thiol proteinase inhibitor. Biochem Biophys Res Commun. 1984 May 31;121(1):149–154. doi: 10.1016/0006-291x(84)90699-5. [DOI] [PubMed] [Google Scholar]
  27. Turk V., Brzin J., Longer M., Ritonja A., Eropkin M., Borchart U., Machleidt W. Protein inhibitors of cysteine proteinases. III. Amino-acid sequence of cystatin from chicken egg white. Hoppe Seylers Z Physiol Chem. 1983 Nov;364(11):1487–1496. doi: 10.1515/bchm2.1983.364.2.1487. [DOI] [PubMed] [Google Scholar]
  28. Vibe-Pedersen K., Sahl P., Skorstengaard K., Petersen T. E. Amino acid sequence of a peptide from bovine plasma fibronectin containing a free sulfhydryl group (cysteine). FEBS Lett. 1982 Jun 1;142(1):27–30. doi: 10.1016/0014-5793(82)80211-1. [DOI] [PubMed] [Google Scholar]
  29. Whur P., Silcox J. J., Boston J. A., Williams D. C. Plasminogen activation transforms the morphology of quiescent 3T3 cell monolayers and initiates growth. Br J Cancer. 1979 Jun;39(6):718–730. doi: 10.1038/bjc.1979.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yamada K. M. Cell surface interactions with extracellular materials. Annu Rev Biochem. 1983;52:761–799. doi: 10.1146/annurev.bi.52.070183.003553. [DOI] [PubMed] [Google Scholar]
  31. Yokosawa H., Ojima S., Ishii S. Thioltrypsin. Chemical transformation of the active-site serine residue of Streptomyces griseus trypsin to a cysteine residue. J Biochem. 1977 Sep;82(3):869–876. doi: 10.1093/oxfordjournals.jbchem.a131763. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES